Schedule 13D ownership disclosure

Ra Pharmaceuticals, Inc.

Security class unavailable · CUSIP: 74933V108

Event date: 2018-12-14

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,584,477
Percent of class
6.1000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001144204-18-066612
Form type
SC 13D/A
Filer
MORGENTHALER VENTURE PARTNERS IX LP
CIK
CIK 1439101
Filed
Dec 31, 2018
Reporting period
Dec 14, 2018
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub